Scientific Advisory Board
SynBERC's Scientific Advisory Board (SAB) provide important advice for the thrusts and the testbeds. These advisors review progress reports, proposals for future work, and the overall scientific goals of the project. The SAB gives input to the SynBERC Leadership Team on the strengths, weaknesses, opportunities, and threats of the SynBERC scientific program. The SAB has recently been expanded to include experts who can help us address emerging needs in the areas of industry and the Practices thrust.
SynBERC Scientific Advisory Board Members:
| Richard Baltz |
Chief Scientific Officer | CognoGen Biotechnology Consulting |
| Jef Boeke | Department of Molecular Biology and Genetics | Johns Hopkins University School of Medicine |
| Douglas Cameron | Alberti Advisors |
|
| James J. Collins |
Center for Biodynamics | Boston University |
| Maitreya Dunham | Genome Sciences |
University of Washington |
| Michael Elowitz | Biology and Applied Physics | Caltech |
| Brent Erickson | Exec. VP, Industrial and Environmental Section | Biotechnology Industry Organization (BIO) |
| Eri Gentry | Founding President & CEO | BioCurious |
| George Khushf |
Bioethics and Medical Humanities | University of South Carolina |
| David Rejeski | Director, Science and Technology Innovation Program | Woodrow Wilson Center |
| Martin Rosenberg |
Chief Scientific Officer |
Promega Corporation |
| Edward H. You (Ex-officio) | Special Agent, Biological Countermeasures Unit | Federal Bureau of Investigation (FBI) |
